News Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:39 2026-05-14 pm EDT			5-day change	1st Jan Change
113.41 ^USD	-0.04%		-0.13%	+7.74%

May. 13	European shares lifted by miners and tech; Mideast in focus	RE
May. 12	Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at Asco 2026	RE

All News

Mentions Relevance

May. 12	Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at Asco 2026	RE
May. 12	Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026	BU
May. 12	Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research At Asco 2026	CI
May. 08	Merck : Statement on Daiichi Sankyo Update to Manufacturing and Supply Plan - Merck.com	PU
May. 07	Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate	BU
May. 05	Merck Completes Terns Pharmaceuticals Acquisition	MT
May. 05	Merck Completes Acquisition of Terns Pharmaceuticals, Inc.	BU
May. 01	Goldman Sachs Adjusts Merck Price Target to $137 From $133	MT
May. 01	Wells Fargo Adjusts Merck Price Target to $145 From $150	MT
May. 01	Morgan Stanley Raises Price Target on Merck to $112 From $109, Keeps Equalweight Rating	MT
Apr. 30	Merck beats quarterly sales expectations as Keytruda fuels growth	RE
Apr. 30	Merck Q1 adjusted loss per share $1.28 versus IBES estimate $-1.51	RE
Apr. 30	Merck posts quarterly loss due to Cidara charge, sales rise 5%	RE
Apr. 30	Merck & Co., Inc., Q1 2026 Earnings Call, Apr 30, 2026
Apr. 30	Merck 1Q Sales Rise on Continued Keytruda Growth -- Update	DJ
Apr. 30	Merck & Co., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 30	Merck beats quarterly sales expectations as Keytruda fuels growth	RE
Apr. 30	Merck Swings to Q1 Adjusted Loss, Sales Rise; 2026 Outlook Updated; Shares Up Pre-Bell	MT
Apr. 30	Earnings Flash (MRK) Merck & Co., Inc., Rahway, N.J., USA Reports Q1 Revenue $16.29B, vs. FactSet Est of $15.85B	MT
Apr. 30	(MRK) Merck Expects 2026 Sales Range $65.8B - $67.0B, vs. FactSet Est of $66.58B	MT
Apr. 30	Earnings Flash (MRK) Merck & Co., Inc., Rahway, N.J., USA Posts Q1 Adjusted Loss $1.28 per Share, vs. FactSet Est of $-1.47	MT
Apr. 30	(MRK) Merck Expects 2026 Adjusted EPS Range $5.04-$5.16, vs. FactSet Est of $5.10	MT
Apr. 30	Merck : Icon 1Q26 Merck Earnings Announcement	PU
Apr. 30	Merck 1Q Sales Rise on Continued Keytruda Growth	DJ
Apr. 30	Merck : Icon 1Q26 Merck Earnings Presentation	PU